Literature DB >> 5882880

In vitro inhibition of rubella virus by 1-adamantanamine hydrochloride.

J S Oxford, G C Schild.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5882880     DOI： 10.1007/bf01267916

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  13 in total

1.  CONGENITAL RUBELLA INFECTION OF A HUMAN EMBRYO.

Authors:  H E KAY; M E PEPPERCORN; J S PORTEFIELD; K MCCARTHY; C H TAYLOR-ROBINSON
Journal:  Br Med J       Date:  1964-07-18

2.  ISOLATION OF RUBELLA VIRUS FROM CASES IN BRITAIN.

Authors:  K MCCARTHY; C H TAYLOR-ROBINSON; S E PILLINGER
Journal:  Lancet       Date:  1963-09-21       Impact factor: 79.321

3.  Ethylene maleic anhydride copolymers as viral inhibitors.

Authors:  E T FELTZ; W REGELSON
Journal:  Nature       Date:  1962-11-17       Impact factor: 49.962

4.  A comparison of methods for estimating the viable count of a suspension of tumour cells.

Authors:  J M HOSKINS; G G MEYNELL; F K SANDERS
Journal:  Exp Cell Res       Date:  1956-08       Impact factor: 3.905

5.  Protection of embryonated eggs infected with infectious bronchitis or Newcastle disease virus by polypeptides.

Authors:  M GREEN; M A STAHMANN; A F RASMUSSEN
Journal:  Proc Soc Exp Biol Med       Date:  1953-07

6.  Inhibitory effect of synthetic lysine polypeptides on growth of influenza virus in embryonated eggs.

Authors:  J R RUBINI; A F RASMUSSEN; M A STAHMANN
Journal:  Proc Soc Exp Biol Med       Date:  1951-04

7.  Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride.

Authors:  G C Schild; R N Sutton
Journal:  Br J Exp Pathol       Date:  1965-06

8.  Determination of the type of nucleic acid in rubella virus using 5-bromo-2'-deoxyuridine.

Authors:  J S Oxford; C E Potter; R N Sutton
Journal:  Nature       Date:  1965-07-17       Impact factor: 49.962

9.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

10.  Growth characteristics of influenza virus: the influence of a sulfonic acid.

Authors:  W W ACKERMANN; H F MAASSAB
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307
View more
  4 in total

1.  Adamantanamine and early events following influenza virus infection.

Authors:  W F Long; J Olusanya
Journal:  Arch Gesamte Virusforsch       Date:  1972

2.  The evaluation of antiviral compounds for rubella virus using organ cultures.

Authors:  J S Oxford; G C Schild
Journal:  Arch Gesamte Virusforsch       Date:  1967

3.  Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C.

Authors:  G Teuber; T Berg; U Naumann; J Raedle; S Brinkmann; U Hopf; S Zeuzem
Journal:  J Viral Hepat       Date:  2001-07       Impact factor: 3.728

4.  Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C.

Authors:  S Zeuzem; G Teuber; U Naumann; T Berg; J Raedle; S Hartmann; U Hopf
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.